logo-loader
viewBoundless Bio

Boundless Bio takes big steps forward filling out their staff

Boundless Bio CEO Zachary Hornby sat down with Proactive’s Christine Corrado at BIO CEO in New York. is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA  to deliver transformative therapies to patients with previously intractable cancers.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Co-Diagnostics expects to win a CE mark-validated...

Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan tells Proactive the Utah-based company expects to achieve a CE mark validation on its coronavirus detection test from the European Union by as early as next week. Egan says the company is very enthused by the entire process of the development...

17 hours, 48 minutes ago

2 min read